切换至 "中华医学电子期刊资源库"
高级检索
中华细胞与干细胞杂志(电子版)

中华细胞与干细胞杂志(电子版) ›› 2019, Vol. 09 ›› Issue (06) : 351 -357. doi: 10.3877/cma.j.issn.2095-1221.2019.06.006

所属专题： 文献；

论著

骨髓间充质干细胞对重症急性胰腺炎胰腺组织修复的促进作用研究
钱道海1, 宋国栋2, 张洲1, 马志龙2, 王冠男1, 于文建1, 陈鹏1, 王小明1,†()   
  1. 1. 241001　芜湖，安徽省芜湖市皖南医学院附属弋矶山医院肝胆外科
    2. 270002　上海，同济大学附属第十人民医院肝胆外科
  • 收稿日期:2019-08-18 出版日期:2019-12-01
  • 通信作者: 王小明
  • 基金资助:
    安徽省教育厅高校自然基金重点项目(KJ2017A271); 安徽省中央引导地方科技发展专项基金(YDZX20183400004899); 弋矶山医院引进人才科研基金(YR201601); 弋矶山医院科研能力"高峰"培育计划项目(GF2019G03)

Positive effect of bone marrow-derived mesenchymal stem cells on the repair of pancreatic tissue in severe acute pancreatitis

Daohai Qian1, Guodong Song2, Zhou Zhang1, Zhilong Ma2, Guannan Wang1, Wenjian Yu1, Peng Chen1, Xiaoming Wang1,†()   

  1. 1. Hepato-biliary Surgery, Yijishan Hospital, Wannan Medical College, Wuhu 241001, China
    2. Hepato-biliary Surgery, the Tenth People's Hospital, Affiliated to Tongji University, Shanghai 270002, China
  • Received:2019-08-18 Published:2019-12-01
  • Corresponding author: Xiaoming Wang
  • About author:
    Corresponding author: Wang Xiaoming, Email:
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

钱道海, 宋国栋, 张洲, 马志龙, 王冠男, 于文建, 陈鹏, 王小明. 骨髓间充质干细胞对重症急性胰腺炎胰腺组织修复的促进作用研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2019, 09(06): 351-357.

Daohai Qian, Guodong Song, Zhou Zhang, Zhilong Ma, Guannan Wang, Wenjian Yu, Peng Chen, Xiaoming Wang. Positive effect of bone marrow-derived mesenchymal stem cells on the repair of pancreatic tissue in severe acute pancreatitis[J/OL]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2019, 09(06): 351-357.

目的

观察骨髓间充质干细胞（BMSCs）抑制坏死性凋亡促进修复重症急性胰腺炎（SAP）的可能机理。

方法

（1）分离、培养和鉴定大鼠BMSCs；（2）构建牛磺胆酸钠（NaT）诱导的SAP大鼠模型，并分成正常组（NC）、假手术组（Sham）、SAP模型组（SAP）、PBS治疗组（PBS）、BMSCs治疗组和Necrostain-1 （Nec-1）治疗组，并检测胰腺病理评分和血淀粉酶水平；（3）运用Western Blot和qRT-PCR方法检测各组受损胰腺组织内RIPK1、RIPK3、Caspase-8、MLKL蛋白及mRNA表达，各组均数间比较采用单因素方差分析，两两比较采用LSD-t检验。

结果

BMSCs可以被诱导分化成骨、软骨、脂肪，并高表达CD44 （99.82﹪）、CD73 （99.87﹪）、CD90 （99.99﹪）、CD105 （99.78﹪），低表达CD11b （0.65﹪）、CD19 （0.85﹪）、CD34 （0.70﹪）和CD45 （1.20﹪）。SAP组胰腺病理评分（12.90±1.79）及血淀粉酶水平（1052.41±183.12） mU/ ml均高于NC组[评分：0.40±0.52，淀粉酶水平：（236.62±33.21） mU/ ml]和Sham组[评分：0.50±0.53，淀粉酶水平：（242.31±27.94） mU/ ml]（F = 200.275，F = 143.245，P均< 0.001），且SAP组受损胰腺组织内RIPK1、RIPK3、MLKL表达升高、Caspase-8表达降低（F = 179.905，P < 0.001）；BMSCs组和Nec-1治疗组胰腺病理评分及血淀粉酶水平均低于PBS治疗组[评分：7.20±1.23、7.00±1.05比12.60±1.65，F = 200.275，P < 0.001；淀粉酶水平：（452.21±101.68）mU/ml、（570.18±148.47） mU/ml比（972.77±204.29） mU/ml，F = 143.245，P < 0.001]，同时受损胰腺组织内RIPK1、RIPK3、MLKL表达下调、Caspase-8表达升高（F = 179.905，P < 0.001）。

结论

BMSCs可能通过抑制坏死性凋亡通路活化来修复SAP。

关键词: 骨髓间充质干细胞, 重症急性胰腺炎, 组织修复, 动物模型
Objective

To investigate the possible mechanism of bone marrow mesenchymal stem cells (BMSCs) promoting the repair of severe acute pancreatitis (SAP) by inhibiting necropotosis.

Methods

(1) the isolation, culture and identification of rat BMSCs; (2) the rat SAP models induced by sodium sulfonycholate (NaT) were constructed and divided into the normal group (NC) , Sham group (Sham) , SAP model group, PBS treatment group, BMSCs transplantation group and the Necrostain-1 (Nec-1) treatment group. (3) The Western-blot and qRT-PCR were used to detect the protein and mRNA expressions of RIPK1, RIPK3, caspase-8 and MLKL in the damaged pancreatic tissues of each group. One-way anova was used for comparison between the mean values of each group, and LSD-t test was used for pair comparison.

Results

BMSCs could be induced to differentiate into bone, cartilage and fat, with high expressions of CD44 (99.82﹪) , CD73 (99.87﹪) , CD90 (99.99﹪) and CD105 (99.78﹪) , low expressions of CD11b (0.65﹪) , CD19 (0.85﹪) , CD34 (0.70﹪) and CD45 (1.20﹪) . Pancreatic pathology scores (12.90±1.79) and blood amylase level (1052.41±183.12) mU/ml in SAP model group were significantly higher than those in NC group [scores: 0.40±0.52, amylase level: (236.62±33.21) mU/ml] and Sham group [scores: 0.50±0.53, amylase level: (242.31±27.94) mU/ml] (F = 200.275, F = 143.245, P < 0.001) . Moreover, the expressions of RIPK1, RIPK3 and MLKL were significantly increased and the expression of caspase-8 was significantly decreased in the SAP model group (F = 179.905, P < 0.001) . Pancreatic pathology scores and blood amylase level in BMSCs transplantation group and Nec-1 treatment group were significantly lower than those in PBS treatment group [score: 7.20±1.23, 7.00±1.05 vs 12.60±1.65, F = 200.275, P < 0.001; Amylase levels: (452.21±101.68) mU/ ml, (570.18±148.47) mU/ml vs (972.77±204.29) mU/ml, F = 143.245, P < 0.001], while the expressions of RIPK1, RIPK3, MLKL were significantly down-regulated and the expression of caspase-8 was significantly increased in the damaged pancreas (F = 179.905, P < 0.001) .

Conclusion

BMSCs may repair SAP by inhibiting the activation of Necroptosispathway .

Key words: Bone marrow mesenchymal stem cells, Severe acute pancreatitis, Tissue repair, Animal model
表1 目的基因引物序列
基因 前向引物（3'-5'） 反向引物（5'-3'）
RIPK1 TCCTCGTTGACCGTGAC GCCTCCCTCTGCTTGTT
RIPK3 CCAGCTCGTGCTCCTTGACT TTGCGGTCCTTGTAGGTTTG
MLKL TCTCCCAACATCCTGCGTAT TCCCGAGTGGTGTAACCTGTA
Caspase-8 GAGTCTTCTGTACCTGTTCC GATAGTCCTCTTCTCCATCTC
GAPDH CGCTAACATCAAATGGGGTG TTGCTGACAATCTTGAGGGAG
图1 倒置显微镜下观察BMSCs形态
图2 流式细胞分析结果
表2 各组血清淀粉酶水平测定（±s）
分组 例数 胰腺病理评分 淀粉酶（mU/ml）
NC组 6 0.40±0.52 236.62± 33.21
Sham组 6 0.50±0.53 242.31± 27.94
SAP组 6 12.90±1.79a 1052.40±183.10a
PBS组 6 12.60±1.65 972.77±204.29
BMSCs组 6 7.20±1.23b 452.21±101.68b
Nec-1治疗组 6 7.00±1.05b 570.18±148.47b
F值 ? 200.275 143.245
P值 ? < 0.001 < 0.001
表3 各组胰腺组织内RIPK1、RIPK3、MLKL、Caspase-8基因表达情况（±s）
分组 例数 RIPK1 RIPK3 MLKL Caspase-8
NC组 6 0.45±0.06 0.37±0.09 0.28±0.10 2.51±0.13
Sham组 6 0.43±0.11 0.40±0.08 0.35±0.16 2.57±0.19
SAP组 6 1.21±0.09a 0.99±0.13a 1.33±0.11a 0.68±0.14a
PBS组 6 1.31±0.17 0.86±0.09 1.34±0.18 0.78±0.08
BMSCs组 6 0.67±0.13b 0.55±0.07b 0.92±0.12b 1.18±0.14b
Nec-1治疗组 6 0.72±0.08b 0.58±0.11b 0.98±0.15b 1.22±0.10b
F值 ? 127.681 47.296 141.026 304.882
P值 ? < 0.001 < 0.001 < 0.001 < 0.001
图3 倒置显微镜下观察胰腺组织HE染色切片（×200）
图4 胰腺组织内RIPK1、RIPK3、MLKL、Caspase-8蛋白表达
图5 间充质干细胞通过抑制RIPK1/RIPK3调控的环死性凋亡发挥治疗作用
1
Leppäniemi A, Tolonen M, Tarasconi A, et al. 2019 WSES guidelines for the management of severe acute pancreatitis[J]. World J Emerg Surg, 2019, 14: 27.
2
Fu X, Liu G, Halim A, et al. Mesenchymal stem cell migration and tissue repair[J]. Cells, 2019, 8(8).pii:E784.
3
Caplan H, Olson SD, Kumar A, et al. Mesenchymal stromal cell therapeutic delivery: translational challenges to clinical application[J]. Front Immunol, 2019, 10:1645.
4
Munir H, McGettrick HM. Mesenchymal stem cell therapy for autoimmune disease: risks and rewards[J]. Stem Cells Dev, 2015, 24(18):2091-2100.
5
Ansboro S, Roelofs AJ, De Bari C. Mesenchymal stem cells for the management of rheumatoid arthritis: immune modulation, repair or both?[J]. Curr Opin Rheumatol, 2017, 29(2):201-207.
6
Qian D, Gong J, He Z, et al. Bone marrow-derived mesenchymal stem cells repair necrotic pancreatic tissue and promote angiogenesis by secreting cellular growth factors involved in the SDF-1α/CXCR4 axis in rats[J]. Stem cells int, 2015, 2015:306836.
7
Jung K H, Song S U, Yi T, et al. Human bone marrow-derived clonal mesenchymal stem cells inhibit inflammation and reduce acute pancreatitis in rats[J]. Gastroenterology, 2011, 140(3):998-1008.
8
Tu XH, Song JX, Xue XJ, et al. Role of bone marrow-derived mesenchymal stem cells in a rat model of severe acute pancreatitis[J]. World J Gastroenterol, 2012, 18(18):2270-2279.
9
Shan B, Pan H, Najafov A, et al. Necroptosis in development and diseases[J]. Genes Dev, 2018, 32(5/6):327-340.
10
Weinlich R, Oberst A, Beere HM, et al. Necroptosis in development, inflammation and disease[J]. Nat Rev Mol Cell Biol, 2017, 18(2):127-136.
11
Hua J, Gong J, Meng HB, et al. Comparison of different methods for the isolation of mesenchymal stem cells from umbilical cord matrix: Proliferation and multilineage differentiation as compared to mesenchymal stem cells from umbilical cord blood and bone marrow[J]. Cell Biol Int, 2014, 38(2):198-210.
12
郭志国，辛毅. 急性胰腺炎发病机制研究新观点[J]. 中国全科医学, 2018, 21(20):2400-2403.
13
Pietkiewicz S, Eils R, Krammer PH, et al. Combinatorial treatment of CD95L and gemcitabine in pancreatic cancer cells induces apoptotic and RIP1-mediated necroptotic cell death network[J]. Exp Cell Res, 2015, 339(1):1-9.
[1] 陆婷, 范晴敏, 王洁, 万晓静, 许春芳, 董凤林. 超声引导下经皮穿刺置管引流对重症急性胰腺炎的疗效及应用时机的选择[J/OL]. 中华医学超声杂志（电子版）, 2024, 21(05): 511-516.
[2] 王晓梅, 刘冰, 马丽琼, 卢祖静, 苗建军. 基于LASSO-Cox回归分析的非轻症急性胰腺炎死亡风险列线图预测模型的建立和临床应用效果分析[J/OL]. 中华普通外科学文献(电子版), 2024, 18(01): 44-50.
[3] 党军强, 杨雁灵, 汪庆强, 尚琳, 朱磊, 项红军. 主动经皮穿刺引流治疗重症急性胰腺炎并发急性坏死物积聚的疗效分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 671-674.
[4] 张子旭, 郑俊炯, 罗云, 林天歆. 腹腔镜肾部分切除术离体猪肾培训模型的构建[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(03): 277-283.
[5] 唐瑞政, 李舒珏, 吴文起. 果蝇模型在肾结石研究中的应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(03): 214-218.
[6] 张礼刚, 邹志辉, 许顺, 蔡可可, 胡永涛, 梁朝朝. 酒精对慢性非细菌性前列腺炎中T淋巴细胞变化的影响研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(01): 74-81.
[7] 邓瑞锋, 程璐, 周宇林, 刘远灵, 江文聪, 江敏耀, 江福能, 习明. TGF-β1诱导骨髓间充质干细胞外泌体分泌miR-424-3p促进前列腺癌细胞增殖及转移[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(01): 82-89.
[8] 杨阳, 王琤, 周文土, 周冰. Caveolae/Caveolin-1与膜胆固醇共同调控小鼠BMSCs成骨分化[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(03): 137-142.
[9] 袁楠, 黄梦杰, 白云凤, 李晓帆, 罗从娟, 陈健文. 急性肾损伤-慢性肾脏病转化小鼠模型制备的教学要点及学习效果分析[J/OL]. 中华肾病研究电子杂志, 2024, 13(04): 226-230.
[10] 汪鹏飞, 程莹莹, 赵海康. 骨髓间充质干细胞改善神经病理性疼痛的机制探讨[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(04): 230-234.
[11] 初晨宇, 徐强, 饶军华, 李岳锋. 眶上锁孔入路手术建立食蟹猴大脑中动脉闭塞模型[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(01): 8-13.
[12] 宋燕秋, 戚桂艳, 杨双双, 周萍. 重症急性胰腺炎肠道菌群特征及早期肠内营养联合微生态制剂治疗的临床价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 442-447.
[13] 丛黎, 马林, 陈旭, 李文文, 张亮亮, 周华亭. 改良CT严重指数联合炎症指标在重症急性胰腺炎患者胰腺感染预测及预后评估中的研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 432-436.
[14] 汪纾羽, 焦茹, 石运涛. 早期肠内营养和微生态免疫肠内营养对重症急性胰腺炎患者肾损伤的预防效果及影响因素[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(02): 132-136.
[15] 黄晨, 庄炜钊, 刘合祝, 李永生, 王倩, 唐郁宽. 富血小板凝胶联合腔内血管成形术治疗缺血性糖尿病足的研究[J/OL]. 中华介入放射学电子杂志, 2024, 12(01): 27-32.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号